Drug Profile
Tazarotene - Almirall
Alternative Names: LAS41006Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Almirall S.A.
- Class Antiacnes; Antipsoriatics; Esters; Keratolytics; Nicotinic acids; Pyrans; Pyridines; Retinoids; Small molecules
- Mechanism of Action Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Psoriasis
Most Recent Events
- 03 Dec 2018 Chemical structure information added
- 20 Nov 2018 No recent reports of development identified phase-II for Psoriasis in Germany (Topical)
- 07 May 2015 Almirall completes a phase II trial in Psoriasis in Germany (NCT02235480)